IGF2 and colorectal carcinoma: It was revealed by the MEMo method [38] that systematically searches for mutually exclusive genomic events that IGF2 overexpression is correlated to the genomic events involved in PI3K activation suggesting that the IGF1R-IGF2-PI3K signaling might be a potential therapeutic target in CRC [19].